Extracellular Factors Influencing the In Vitro Protein Synthesis of Platelets

 

PDF Download Buy Article Permissions and Reprints

Summary

Regulation of platelet protein synthesis by selected extracellular factors and events have been examined. Protein synthetic function was assessed by the incorporation of ³H-leucine into trichloroacetic acid-precipitable protein and was characterized by: a) incorporation of 0.1 μ moles leucine/hr/10⁸8 platelets; b) sensitivity to puromycin but not actinomycin D; and c) synthesis of multiple size species. Inhibition and potentiation of the rate of protein synthesis by extracellular factors was demonstrable. Plasma and serum both inhibited protein synthesis, and the inhibitory effect appeared to be dependent upon a cooperative effect of two distinct plasma factors. The inhibitory effect may reflect a decrease in the rate of protein synthesis and/or an increase in the rate of protein catabolism. Fibrinogen and its plasmic cleavage products X, Y and E did not affect platelet protein synthesis; but the D: E complex and D fragment produced approximately 50% increases in the rate of synthesis. Protein synthesis and the release reaction appeared to be independent cellular functions as ADP, thrombin, AMP, ATP, adenosine and dibutyryl derivatives of cyclic AMP and GMP did not influence protein synthesis. Epinephrine at 1 mM inhibited the initial rate of protein synthesis by 45%; however, this effect appeared to be independent of the release reaction. It is concluded that platelet protein synthesis in vitro is independent of selected platelet hemostatic functions such as the release reaction but is susceptible to regulation by agents which occur in vivo.

• References

• 1 Agam G, Bessler H, Djaldetti M. 1976; In vitro DNA and RNA synthesis by human platelets. Biochimica et Biophysica Acta 425: 41
  CrossrefPubMedGoogle Scholar
• 2 Bocci V, Conti T, Muscettola M, Pacini A, Pessina GP. 1974; Factors regulating plasma protein synthesis. IV. Influence of fragments D and E on plasma fibrinogen concentration. Thrombosis et Diathesis Haemorrhagica 31: 395
  PubMedGoogle Scholar
• 3 Booyse FM, Rafelson Jr ME. 1967; a Stable messenger RNA in the synthesis of contractile protein in human platelets. Biochimica et Biophysica Acta 145: 188
  CrossrefPubMedGoogle Scholar
• 4 Booyse FM, Rafelson Jr ME. 1967; b In vitro incorporation of amino acids into the contractile protein of human blood platelets. Nature 215: 283
  CrossrefPubMedGoogle Scholar
• 5 Booyse FM, Rafelson Jr ME. 1968; a Studies of human platelets. I. Synthesis of platelet protein in a cell-free system. Biochimica et Biophysica Acta 166: 689
  CrossrefPubMedGoogle Scholar
• 6 Booyse FM, Hoveke TP, Rafelson Jr ME. 1968; b Studies of human platelets. II. Protein synthetic activity of various platelet populations. Biochimica et Biophysica Acta 157: 660
  CrossrefPubMedGoogle Scholar
• 7 Booyse FM, Zschocke D, Hoveke TP, Rafelson Jr ME. 1971; Studies of human platelets IV. Protein synthesis in maturing human platelets Thrombosis et Diathesis Haemorrhagica 26: 167
  PubMedGoogle Scholar
• 8 Born GV R, Haslam RJ, Goldman M, Lowe RD. 1965; Comparative effectiveness of adenosine analogues as inhibitors of blood platelet aggregation and as vasodilators in man. Nature 205: 678
  CrossrefPubMedGoogle Scholar
• 9 Doolittle RF, Schubert D, Schwartz SA. 1967; Amino acid sequence studies on autiodactyl fibrinopeptides. I. Dromedary camel, mule deer, and cape buffalo. Archives of Biochemistry and Biophysics 118: 456
  CrossrefPubMedGoogle Scholar
• 10 Haslam RJ. 1967; Mechanisms of blood platelet aggregation. Physiology of Hemostasis and Thrombosis Thomas, Springfield, IL, p 88
  PubMedGoogle Scholar
• 11 Humphrey JH. 1955; Origin of blood platelets. Nature 176: 38
  PubMedGoogle Scholar
• 12 Jerushalmy Z, Zucker MB. 1966; Some effects of fibrinogen degradation products (fDP) on blood platelets. Thrombosis et Diathesis Haemorrhagica 75: 413
  PubMedGoogle Scholar
• 13 Knutt AA, Gardner FH. 1958; Survival of blood platelets labeled with chromium51. Journal of Clinical Investigation 37: 1257
  CrossrefPubMedGoogle Scholar
• 14 Luganova IS, Seits IF, Teodorovich VI. 1958; Metabolism in human thrombocytes. Biochemistry (Eng. Trans.) 23: 379
  PubMedGoogle Scholar
• 15 Nachman RL, Ferris B. 1968; Studies on human platelet protease activity. Journal of Clinical Investigation 47: 2530
  CrossrefPubMedGoogle Scholar
• 16 Nilehn JE. 1967; Split products of fibrinogen after prolonged interaction with plasmin. Thrombosis et Diathesis Haemorrhagica 18: 89
  PubMedGoogle Scholar
• 17 Packham MA, Ardlie NG, Mustard JF. 1969; The effect of adenine compounds on platelet aggregation. American Journal of Physiology 217: 1009
  PubMedGoogle Scholar
• 18 Plow E, Edgington TS. 1973; Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo Journal of Clinical Investigation 52: 273
  CrossrefPubMedGoogle Scholar
• 19 Reich E, Franklin RM, Shatkin AJ, Tatum EL. 1962; Action of actinomycin D on animal cells and viruses. Proceedings of the National Academy of Sciences USA 98: 1238
  PubMedGoogle Scholar
• 20 Robison GA, Butcher RW, Sutherland EW. 1971. Some actions of cyclic AMP. Cyclic AMP. Academic Press; New York: p 138
  Google Scholar
• 21 Rosier O, Wegrzynowicz. Sawicki Z, Kopec M. 1969; Fibrinogensynthese in Blutplättchen. Folia Hematologica 92: 553
  PubMedGoogle Scholar
• 22 Salzman EW. 1972; Cyclic AMP and platelet function. New England Journal of Medicine 286: 358
  CrossrefPubMedGoogle Scholar
• 23 Steiner M, Baldini M. 1969; Protein synthesis in aging blood platelets. Blood 33: 628
  PubMedGoogle Scholar
• 24 Warshaw AL, Laster L, Shulman NR. 1966; Oxidation in human platelets. Journal of Clinical Investigation 45: 1923
  CrossrefPubMedGoogle Scholar
• 25 Warshaw AL, Laster L, Shulman NR. 1967; Protein synthesis by human platelets. Journal of Biological Chemistry 242: 2094
  PubMedGoogle Scholar
• 26 Weber K, Osborn M. 1969; The reliability of molecular weight determinations by dodecylsul- fate-polyacrylamide gel electrophoresis. Journal of Biological Chemistry 244: 4406
  PubMedGoogle Scholar
• 27 WICKS WD. 1974; Regulation of protein synthesis by cyclic AMP. Advances in Cyclic Nucleotide Research 4: 335
  PubMedGoogle Scholar
• 28 Yarmolinsky MB, De La Haba GL. 1959; Inhibition by puromycin of amino acid incorporation into protein. Proceedings of the National Academy of Sciences USA 45: 1721
  CrossrefPubMedGoogle Scholar